Back to Search
Start Over
CD39 affects the prognostic role of NLR via N2 neutrophils in metastatic melanoma patients treated with immunotherapy
- Publication Year :
- 2023
- Publisher :
- Zenodo, 2023.
-
Abstract
- The immune checkpoint inhibitors (ICIs) revolutionized cancer therapeutic landscape and substantially improved the survival of patients (pts) with advanced malignancies. Several predictive biomarkers are under evaluation, in order to identify patients who can benefit from ICI. Recently, elevated NLR, calculated from absolute neutrophil count and white cell count, were found to be independent predictors of reduced survival and increased risk of progression in melanoma patients receiving ICI. The purpose of this study is to retrospectively investigate relationship of NLR with inflammation-immune mediators.The immune checkpoint inhibitors (ICIs) revolutionized cancer therapeutic landscape and substantially improved the survival of patients (pts) with advanced malignancies. Several predictive biomarkers are under evaluation, in order to identify patients who can benefit from ICI. Recently, elevated NLR, calculated from absolute neutrophil count and white cell count, were found to be independent predictors of reduced survival and increased risk of progression in melanoma patients receiving ICI. The purpose of this study is to retrospectively investigate relationship of NLR with inflammation-immune mediators.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....b8109317a9f78cc1e2d2f9961ea64640
- Full Text :
- https://doi.org/10.5281/zenodo.7924818